The DOI matches its Crossref record; 42 of the 45 references it cites were found in a registry or an index.
Genetic Analysis of BRCA1 Function in a Defined Tumor Cell Line
Open accessAbstract
Retrovirally expressed, wild-type BRCA1 decreased the gamma radiation (IR) sensitivity and increased the efficiency of double-strand DNA break repair (DSBR) of the BRCA1-/- human breast cancer line, HCC1937. It also reduced its susceptibility to DSB generation by IR. By contrast, multiple, clinically validated, missense mutant BRCA1 products were nonfunctional in these assays. These data constitute the basis for a BRCA1 functional assay and suggest that efficient repair of double-strand DNA breaks is linked to BRCA1 tumor suppression function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Confirming the essential role of the BRCTs for BRCA1’s DNA repair function, a breast cancer cell line that expressed a truncated BRCA1 lacking functional BRCTs was defective in DNA repair and sensitive to DNA damage; defects that were reversed upon complementation with a full-length BRCA1 protein [36].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [36]
Citations
Cites
1 retracted
BRCA1 required for transcription-coupled repair of oxidative DNA damage
Gowen, L. C., Avrutskaya, A. V., Latour, A. M., Koller, B. H., & Leadon, S. A. (1998) · Science · doi:10.1126/science.281.5379.1009 · Cited by 496
RetractedAssociation of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Self-citationBrca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2
Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D., Regel, E., Dinh, C. Q., Sands, A., Gregor Eichele, C., Hasty, P., & Bradley, A. (1997) · Nature · doi:10.1038/386804a0 · Cited by 1,087
Cortez, D., Wang, Y., Qin, J., & Elledge, S. J. (1999) · Science · doi:10.1126/science.286.5442.1162 · Cited by 1,020
Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80503-6 · Cited by 900
Self-citationXu, X., Ohler, Z. W., Linke, S. P., Li, C., Gotay, J., Wang, X. W., Harris, C. C., Ried, T., & Deng, C. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80466-9 · Cited by 819
Radiosensitivity in ataxia-telangiectasia: a new explanation.
Painter, R. B., & Young, B. R. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7315 · Cited by 795
Xu, X., Wagner, K., Larson, D. M., Ohler, Z. W., Li, C., Ried, T., Hennighausen, L. G., Wynshaw-Boris, A. J., & Deng, C. (1999) · Nature Genetics · doi:10.1038/8743 · Cited by 766
Cited by
Sorted by citations
Items 101–200 of 358
Structural Consequences of a Cancer-causing BRCA1-BRCT Missense Mutation
Williams, R. S., & Glover, J. N. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210019200 · Cited by 101
Classification of BRCA1 missense variants of unknown clinical significance
Phelan, C. M., Đapic, V., Tice, B., Favis, R., Kwan, E., Barany, F., Manoukian, S., Radice, P., van der Luijt, R. B., van Nesselrooij, B. P. M., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.024711 · Cited by 101
Davalos, A. R., & Campisi, J. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304016 · Cited by 103
A single mutated BRCA1 allele leads to impaired fidelity of double strand break end-joining
Baldeyron, C., Jacquemin, E., Smith, J., Jacquemont, C. F., Oliveira, I. D., Gad, S., Feunteun, J., Stoppa‐Lyonnet, D., & Papadopoulo, D. (2002) · Oncogene · doi:10.1038/sj.onc.1205200 · Cited by 99
Farnesyltransferase Inhibitors Induce DNA Damage via Reactive Oxygen Species in Human Cancer Cells
Pan, J., She, M., Xu, Z., Sun, L., & Yeung, S. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2744 · Cited by 97
Cytoplasmic mislocalization of BRCA1 caused by cancer-associated mutations in the BRCT domain
Rodríguez, J. A., Au, W. W. Y., & Henderson, B. R. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.09.027 · Cited by 96
Role of BRCA1 in brain development
Pao, G. M., Zhu, Q., Pérez‐García, C. G., Chou, S., Suh, H., Gage, F. H., O’Leary, D. D. M., & Verma, I. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400783111 · Cited by 101
BRCA1 Deficiency Impairs Mitophagy and Promotes Inflammasome Activation and Mammary Tumor Metastasis
Chen, Q., Lei, J. H., Bao, J., Wang, H., Hao, W., Li, L., Peng, C., Masuda, T., Miao, K., Xu, J., et al. (2020) · Advanced Science · doi:10.1002/advs.201903616 · Cited by 96
Biochemical DSB-repair model for mammalian cells in G1 and early S phases of the cell cycle
Taleei, R., & Nikjoo, H. (2013) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2013.06.004 · Cited by 94
Xu, Y., Diao, L., Chen, Y., Liu, Y., Wang, C. Y., Ouyang, T., Li, J., Wang, T., Fan, Z., Fan, T., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt011 · Cited by 89
BACH1 is a DNA repair protein supporting BRCA1 damage response
Peng, M., Litman, R., Jin, Z., Fong, G., & Cantor, S. B. (2006) · Oncogene · doi:10.1038/sj.onc.1209257 · Cited by 88
Wang, Q., Zhang, H., Fishel, R. A., & Greene, M. I. (2000) · Oncogene · doi:10.1038/sj.onc.1203974 · Cited by 87
BRCA1: exploring the links to transcription
Monteiro, Á. N. A. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01632-7 · Cited by 87
The XIST Noncoding RNA Functions Independently of BRCA1 in X Inactivation
Xiao, C., Sharp, J. A., Kawahara, M., Davalos, A. R., Difilippantonio, M. J., Hu, Y., Li, W., Cao, L., Buetow, K. H., Ried, T., et al. (2007) · Cell · doi:10.1016/j.cell.2007.01.034 · Cited by 85
NEK1 loss-of-function mutation induces DNA damage accumulation in ALS patient-derived motoneurons
Higelin, J., Catanese, A., Semelink-Sedlacek, L. L., Oeztuerk, S., Lutz, A.-K., Bausinger, J., Barbi, G., Speit, G., Andersen, P. M., Ludolph, A. C., et al. (2018) · Stem Cell Research · doi:10.1016/j.scr.2018.06.005 · Cited by 86
BRCC36 Is Essential for Ionizing Radiation–Induced BRCA1 Phosphorylation and Nuclear Foci Formation
Chen, X., Arciero, C. A., Wang, C., Broccoli, D., & Godwin, A. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4194 · Cited by 82
Lovelock, P. K., Spurdle, A. B., Mok, M. T. S., Farrugia, D. J., Lakhani, S. R., Healey, S. C., Arnold, S., Buchanan, D. D., kConFab Investigators, Couch, F. J., et al. (2007) · Breast Cancer Research · doi:10.1186/bcr1826 · Cited by 81
Spiro, C., & McMurray, C. T. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6063-6074.2003 · Cited by 78
Role of BRCAgene dysfunction in breast and ovarian cancer predisposition
Scully, R. (2000) · Breast Cancer Research · doi:10.1186/bcr76 · Cited by 78
Self-citationZhu, W., & Dutta, A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02141-05 · Cited by 79
Okada, S., & Ouchi, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208685200 · Cited by 76
Coluccio, M. L., Gentile, F., Das, G., Nicastri, A., Perri, A., Candeloro, P., Perozziello, G., Zaccaria, R. P., Gongora, J. S. T., Alrasheed, S., et al. (2015) · Science Advances · doi:10.1126/sciadv.1500487 · Cited by 75
p53-Dependent BRCA1 Nuclear Export Controls Cellular Susceptibility to DNA Damage
Jiang, J., Yang, E. S.-H., Jiang, G., Nowsheen, S., Wang, H., Wang, T., Wang, Y., Billheimer, D. D., Chakravarthy, A. B., Brown, M. A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3423 · Cited by 76
Zhou, C., Smith, J. L., & Liu, J. (2003) · Oncogene · doi:10.1038/sj.onc.1206319 · Cited by 74
Pesaran, T. F., Karam, R., Huether, R., Li, S., Farber-Katz, S., Chamberlin, A. C., Chong, H. K., LaDuca, H., & Elliott, A. M. (2016) · International Journal of Breast Cancer · doi:10.1155/2016/2469523 · Cited by 74
Viral Transport of DNA Damage That Mimics a Stalled Replication Fork
Jurvansuu, J., Raj, K., Stasiak, A., & Beard, P. (2004) · Journal of Virology · doi:10.1128/jvi.79.1.569-580.2005 · Cited by 71
Rapid Recruitment of BRCA1 to DNA Double-Strand Breaks Is Dependent on Its Association with Ku80
Wei, L., Lan, L., Hong, Z., Yasui, A., Ishioka, C., & Chiba, N. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01075-08 · Cited by 78
Repression of BRCA1 through a Feedback Loop Involving p53
MacLachlan, T. K., Dash, B. C., Dicker, D. T., & El‐Deiry, W. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003338200 · Cited by 70
Weberpals, J. I., Clark-Knowles, K. V., & Vanderhyden, B. C. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.3902 · Cited by 71
X-Ray Structures of the LXRα LBD in Its Homodimeric Form and Implications for Heterodimer Signaling
Fradera, X., Vu, D., Nimz, O., Skene, R. J., Hosfield, D. J., Wynands, R., Cooke, A., Haunsø, A., King, A. W. T., Bennett, D. J., et al. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.04.005 · Cited by 69
DNA polymerase stalling, sister chromatid recombination and the BRCA genes
Scully, R., Puget, N., & Vlasáková, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203971 · Cited by 68
Self-citationWillers, H., Gheorghiu, L., Liu, Q., Efstathiou, J. A., Wirth, L. J., Krause, M., & von Neubeck, C. (2015) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2015.05.007 · Cited by 69
BRCA1 in the DNA damage response and at telomeres
Rosen, E. M. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00085 · Cited by 68
Francisco, D., Peddi, P., Hair, J. M., Flood, B., Cecil, A. M., Kalogerinis, P. T., Sigounas, G., & Georgakilas, A. G. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.10.045 · Cited by 67
Burga, L. N., Tung, N., Troyan, S. L., Bostina, M., Konstantinopoulos, P. A., Fountzilas, H., Spentzos, D., Miron, A., Yassin, Y., Lee, B. T., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2954 · Cited by 68
Recognition of DNA double strand breaks by the BRCA1 tumor suppressor network
Greenberg, R. A. (2008) · Chromosoma · doi:10.1007/s00412-008-0154-8 · Cited by 69
Both DNA topoisomerase II-binding protein 1 and BRCA1 regulate the G2-M cell cycle checkpoint.
Yamane, K., Chen, J., & Kinsella, T. J. (2003) · PubMed · Cited by 66
Self-citationThe role of BRCA1 in non-homologous end-joining
Bau, D., Mau, Y.-C., & Shen, C. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.08.003 · Cited by 65
Identification of a Small Molecule Inhibitor of RAD52 by Structure-Based Selection
Sullivan, K., Cramer-Morales, K. L., McElroy, D. L., Ostrov, D. A., Haas, K., Childers, W. E., Hromas, R., & Skórski, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147230 · Cited by 67
Nikkilä, J., Coleman, K. A., Morrissey, D., Pylkäs, K., Erkko, H., Messick, T. E., Karppinen, S.-M., Amelina, A., Winqvist, R., & Greenberg, R. A. (2009) · Oncogene · doi:10.1038/onc.2009.33 · Cited by 63
BRCA Gene Structure and Function in Tumor Suppression
Murphy, C. G., & Moynahan, M. E. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181cf0204 · Cited by 63
Au, W. W. Y., & Henderson, B. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408879200 · Cited by 61
Chk1 is required to maintain Claspin stability
Chini, C. C. S., Wood, J., & Chen, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209447 · Cited by 62
Self-citationIndependence of R/M/N Focus Formation and the Presence of Intact BRCA1
Wu, X. (2000) · Science · doi:10.1126/science.289.5476.11a · Cited by 61
BRCA1 and BRCA2: The genetic testing and the current management options for mutation carriers
Palma, M., Ristori, E., Ricevuto, E., Giannini, G., & Gulino, A. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.05.003 · Cited by 61
Pageau, G. J., Hall, L. L., & Lawrence, J. B. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21188 · Cited by 60
Fridlich, R., Annamalai, D., Roy, R., Bernheim, G., & Powell, S. N. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.03.002 · Cited by 67
BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest
Ongusaha, P. P., Ouchi, T., Kim, K., Nytko, E. A., Kwak, J. C., Duda, R. B., Deng, C., & Lee, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206439 · Cited by 56
The molecular basis of radiosensitivity and chemosensitivity in the treatment of breast cancer
Xia, F., & Powell, S. N. (2002) · Seminars in Radiation Oncology · doi:10.1053/srao.2002.35250 · Cited by 57
Wang, H., Yang, E. S.-H., Jiang, J., Nowsheen, S., & Xia, F. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4713 · Cited by 58
Basal-Like Breast Cancer: Update on Clinicopathologic, Immunohistochemical, and Molecular Features
Leidy, J., Khan, A. A., & Kandil, D. H. (2013) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2012-0439-ra · Cited by 57
Reyngold, M., Nandula, S. V., Modi, A. P., Wang, S., Jasin, M., Murty, V. V. V. S., Ludwig, T., & Baer, R. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705198200 · Cited by 56
BRCA1 and p53: compensatory roles in DNA repair
Hartman, A., & Ford, J. M. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0477-0 · Cited by 62
BRCA1 Mutation: A Predictive Marker for Radiation Therapy?
Kan, C. E., & Zhang, J. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.05.037 · Cited by 54
Functional assays for BRCA1 and BRCA2
Carvalho, M. A., Couch, F. J., & Monteiro, Á. N. A. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.08.002 · Cited by 58
Chen, Q.-X., Wang, X.-X., Lin, P.-Y., Zhang, J., Li, J.-J., Song, C.-G., & Shao, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.13976 · Cited by 54
BRCA1 16 years later: risk‐associated BRCA1 mutations and their functional implications
Linger, R. J., & Kruk, P. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07735.x · Cited by 52
Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH
Joosse, S. A., Brandwijk, K. I. M., Devilee, P., Wesseling, J., Hogervorst, F. B. L., Verhoef, S., & Nederlof, P. M. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1016-7 · Cited by 53
Functional and physical interaction between the mismatch repair and FA-BRCA pathways
Williams, S. A., Wilson, J. B., Clark, A. P., Mitson‐Salazar, A., Tomashevski, A., Ananth, S., Glazer, P. M., Semmes, O. J., Bale, A. E., Jones, N. J., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr366 · Cited by 52
Ali, R., McIntosh, S., & Savage, K. I. (2020) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22921 · Cited by 52
Sadeghi, F., Asgari, M., Matloubi, M., Ranjbar, M., Yousefi, N. K., Azari, T., & Zaki‐Dizaji, M. (2020) · Biological Procedures Online · doi:10.1186/s12575-020-00133-5 · Cited by 55
BRCA1-induced Apoptosis Involves Inactivation of ERK1/2 Activities
Yan, Y., Haas, J. P., Kim, M., Sgagias, M. K., & Cowan, K. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201147200 · Cited by 50
RetractedGenome‐wide analysis reveals a role for BRCA1 and PALB2 in transcriptional co‐activation
Gardini, A., Baillat, D., Cesaroni, M., & Shiekhattar, R. (2014) · The EMBO Journal · doi:10.1002/embj.201385567 · Cited by 51
Mutations in the BRCT binding site of BRCA1 result in hyper-recombination
Dever, S. M., Golding, S. E., Rosenberg, E., Adams, B. R., Idowu, M. O., Quillin, J. M., Valerie, N. C. K., Xu, B., Povirk, L. F., & Valerie, K. C. (2011) · Aging · doi:10.18632/aging.100325 · Cited by 50
BRCT Domains: phosphopeptide binding and signaling modules
María, C. (2008) · Frontiers in bioscience · doi:10.2741/3125 · Cited by 51
Hair, J. M., Terzoudi, G. I., Hatzi, V. I., Lehockey, K. A., Srivastava, D., Wang, W., Pantelias, G. E., & Georgakilas, A. G. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.03.046 · Cited by 48
Gopala, S., Annab, L. A., Gopinath, G., Banerji, A., & Srinivas, P. (2003) · Molecular Carcinogenesis · doi:10.1002/mc.10164 · Cited by 47
AKT regulates BRCA1 stability in response to hormone signaling
Nelson, A., Lyons, T. R., Young, C. D., Hansen, K. C., Anderson, S. M., & Holt, J. T. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.01.019 · Cited by 46
BRCA1 Pathway Function in Basal-Like Breast Cancer Cells
Hill, S. J., Clark, A. P., Silver, D. P., & Livingston, D. M. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01646-13 · Cited by 44
Self-citationRass, E., Chandramouly, G., Zha, S., Alt, F. W., & Xie, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.445825 · Cited by 43
c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells
Chen, Y., Xu, J., Borowicz, S., Collins, C., Huo, D., & Olopade, O. I. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-246 · Cited by 45
kConFab, Tischkowitz, M. D., Hamel, N., Carvalho, M. A., Birrane, G., Soni, A., van Beers, E. H., Joosse, S. A., Wong, N., Novak, D. J., et al. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.13 · Cited by 45
Brca1-Deficient Murine Mammary Epithelial Cells have Increased Sensitivity to CDDP and MMS
Sgagias, M. K., Wagner, K., Hamik, B., Stoeger, S. M., Spieker, R. S., Huber, L. J., Chodosh, L. A., & Cowan, K. H. (2004) · Cell Cycle · doi:10.4161/cc.3.11.1211 · Cited by 44
Grigorova, M., Staines, J. M., Özdağ, H., Caldas, C., & Edwards, P. A. (2004) · Cytogenetic and Genome Research · doi:10.1159/000077512 · Cited by 43
Chromosomal mutagen sensitivity associated with mutations in BRCA genes
Speit, G., & Trenz, K. (2004) · Cytogenetic and Genome Research · doi:10.1159/000077511 · Cited by 43
Association of BRCA1 with the inactive X chromosome and XIST RNA
Ganesan, S., Silver, D. P., Drapkin, R., Greenberg, R. A., Feunteun, J., & Livingston, D. M. (2004) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2003.1371 · Cited by 43
Self-citationPolo-like kinase 1 mediates BRCA1 phosphorylation and recruitment at DNA double-strand breaks
Chabalier-Taste, C., Brichese, L., Racca, C., Canitrot, Y., Calsou, P., & Larminat, F. (2016) · Oncotarget · doi:10.18632/oncotarget.6825 · Cited by 42
Hu, Y., Miyake, T., Ye, Q., & Li, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000607200 · Cited by 42
Choudhary, S. K., & Li, R. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10081 · Cited by 42
HumanBRCA1 gene rescues the embryonic lethality ofBrca1 mutant mice
Chandler, J., Hohenstein, P., Swing, D. A., Tessarollo, L., & Sharan, S. K. (2001) · genesis · doi:10.1002/1526-968x(200102)29:2 · Cited by 42
Caligo, M. A., Bonatti, F., Guidugli, L., Aretini, P., & Galli, A. (2008) · Human Mutation · doi:10.1002/humu.20817 · Cited by 41
Jeon, G. S., Kim, K. Y., Hwang, Y. J., Jung, M.-K., An, S., Ouchi, M., Ouchi, T., Kowall, N. W., Lee, J.-H., & Ryu, H. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8274-9 · Cited by 46
Phosphorylation of ribosomal protein S6 confers PARP inhibitor resistance in BRCA1-deficient cancers
Sun, C., Zhang, F., Xiang, T., Chen, Q., Pandita, T. K., Huang, Y., Hu, M. C. ‐., & Yang, Q. (2014) · Oncotarget · doi:10.18632/oncotarget.1952 · Cited by 40
Oishi, H., Kitagawa, H., Wada, O., Takezawa, S., Tora, L., Kouzu‐Fujita, M., Takada, I., Yano, T., Yanagisawa, J., & Kato, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510157200 · Cited by 45
RetractedNelson, A., & Holt, J. T. (2010) · Radiation Research · doi:10.1667/rr1290.1 · Cited by 40
Zhang, F., Bick, G., Park, J., & Andreassen, P. R. (2012) · Journal of Cell Science · doi:10.1242/jcs.111872 · Cited by 42
Bright, S. J., Flint, D. B., Chakraborty, S., McFadden, C. H., Yoon, D. S., Bronk, L. F., Titt, U., Mohan, R., Grosshans, D. R., Sumazin, P., et al. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.08.011 · Cited by 42
BRCA1 and BRCA2 in hereditary breast cancer
Scully, R., & Puget, N. (2002) · Biochimie · doi:10.1016/s0300-9084(01)01359-1 · Cited by 46
Self-citationAssessing the Link between BACH1 and BRCA1 in the FA Pathway
Cantor, S. B., & Andreassen, P. R. (2005) · Cell Cycle · doi:10.4161/cc.5.2.2338 · Cited by 39
Akt1 inhibits homologous recombination in Brca1-deficient cells by blocking the Chk1-Rad51 pathway
Jia, Y., Song, W. M., Zhang, F., Yan, J., & Yang, Q. (2012) · Oncogene · doi:10.1038/onc.2012.211 · Cited by 37
Coupier, I., Baldeyron, C., Rousseau, A., Mosseri, V., Pagès-Berhouet, S., Caux‐Moncoutier, V., Papadopoulo, D., & Stoppa‐Lyonnet, D. (2003) · Oncogene · doi:10.1038/sj.onc.1207191 · Cited by 37
Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1
Ree, A. H., Bratland, Å., Nome, R. V., Stokke, T., & Fodstad, Ø. (2003) · Oncogene · doi:10.1038/sj.onc.1207000 · Cited by 38
Wu, Y., & Brosh, R. M. (2009) · Current Molecular Medicine · doi:10.2174/156652409788167159 · Cited by 37
Kononenko, A. V., Bansal, R., Lee, N., Grimes, B. R., Masumoto, H., Earnshaw, W. C., Larionov, V., & Kouprina, N. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku870 · Cited by 36
Understanding Germ-Line Mutations inBRCA1
Szabo, C. I., Worley, T., & Monteiro, Á. N. A. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.6.841 · Cited by 37
BRCA1 Circos: a visualisation resource for functional analysis of missense variants
Jhuraney, A., Velkova, A., Johnson, R. C., Kessing, B. D., Carvalho, R. S., Whiley, P. J., Spurdle, A. B., Vreeswijk, M. P. G., Caputo, S. M., Millot, G. A., et al. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102766 · Cited by 35
Wiltshire, T. D., Senft, J., Wang, Y., Konat, G. W., Wenger, S. L., Reed, E., & Wang, W. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.029504 · Cited by 34
BRCA1—A good predictive marker of drug sensitivity in breast cancer treatment?
Mullan, P. B., Gorski, J. J., & Harkin, D. P. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.07.001 · Cited by 34
Tutt, A. N. J., & Yarnold, J. R. (2005) · Clinical Oncology · doi:10.1016/j.clon.2005.11.011 · Cited by 33
Up‐regulation of the interferon‐related genes in BRCA2 knockout epithelial cells
Xu, H., Xian, J., Viré, E. A., McKinney, S. E., Wei, V., Wong, J. W. H., Tong, R., Kouzarides, T., Caldas, C., & Aparicio, S. A. J. R. (2014) · The Journal of Pathology · doi:10.1002/path.4404 · Cited by 33
Metadata
- Authors
- Scully, R., Ganesan, S., Vlasakova, K., Chen, J., Socolovsky, M., & Livingston, D. M.
- Affiliations
- Harvard University (US)
- Massachusetts Institute of Technology (US)
- Corresponding author
- Livingston, David M
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 1999-12
- Volume
- 4
- Issue
- 6
- Pages
- 1093-1099
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W1976960697
- Cited by
- 359
- References
- 45
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 2 · 2023: 7 · 2022: 6 · 2021: 8 · 2020: 10 · 2019: 8 · 2018: 4 · 2017: 5 · 2016: 8 · 2015: 13 · 2014: 14 · 2013: 13 · 2012: 13
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL032262, HL-32262)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- BRCA1, DNA double-strand break repair, radiosensitivity, missense mutations, tumor suppression, retroviral gene expression, functional assays
- MeSH terms
- Breast Neoplasms, DNA Repair, Female, Genetic Vectors, Humans, Radiation Tolerance, Retroviridae, Tumor Cells, Cultured, Gene Expression Regulation, Neoplastic, Gene Transfer Techniques, BRCA1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review